Medicines

The World Health Organization (WHO) announced a new project to advance the development of an mRNA vaccine targeting human avian influenza (H5N1).

Last week, Moderna announced that it has received approval from the Food and Drug Administration (FDA) for the development of an mRNA vaccine for respiratory syncytial virus (RSV).

Moderna reported a $1.2 billion loss in the first quarter of 2024.

Last week, the White House signed onto a global health security (GHS) program alongside 50 other countries.

A review published earlier this month linked the mRNA in COVID-19 vaccines to the development of cancer.

Global Health professor at the University of Southern Denmark Christine Stabell Benn revealed that the increase in all-cause mortality is linked to childhood vaccines.

Moderna recently announced that it is developing more mRNA vaccines targeting Epstein-Barr virus (EBV), Varicella-zoster virus (VZV, chickenpox, and shingles), and Norovirus.

CVS is voluntarily removing over-the-counter cough and cold products from its shelves after a Food and Drug Administration advisory panel confirmed the active ingredients of America’s leading decongestive “medicines” do not work.

Gates also funds pharmaceutical treatments for tick-borne illnesses.

An analysis by Accountable.US found that the five largest pharmaceutical companies in the United States made $82 billion in 2022.